Bain Capital Life Sciences Investors’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $632K | Hold |
|
|||||
|
2024
Q3 | $5.91M | Buy |
|
|||||
|
2024
Q2 | $14.2M | Hold |
|
|||||
|
2024
Q1 | $14.7M | Hold |
|
|||||
|
2023
Q4 | $21.4M | Buy |
|
|||||
|
2023
Q3 | $8.39M | Hold |
|
|||||
|
2023
Q2 | $6.69M | Hold |
|
|||||
|
2023
Q1 | $5.67M | Hold |
|
|||||
|
2022
Q4 | $7.63M | Buy |
|
|||||
|
2022
Q3 | $6.97M | Buy |
|
|||||
|
2022
Q2 | $6.03M | Hold |
|
|||||
|
2022
Q1 | $7.46M | Hold |
|
|||||
|
2021
Q4 | $20.4M | Buy |
|
|||||
|
2021
Q3 | $25.9M | Hold |
|
|||||
|
2021
Q2 | $31.5M | Hold |
|
|||||
|
2021
Q1 | $43.3M | Hold |
|
|||||
|
2020
Q4 | $62.8M | Buy |
|